Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ARD-07 bioavailability reduced by food

July 8, 2008

Encouraging results seen with Chronocort in congenital adrenal hyperplasia

July 8, 2008

Selective androgen receptor modulator-like properties seen with MK-0773

July 8, 2008

Shire to launch a voluntary public takeover offer for shares in Jerini

July 7, 2008

AstraZeneca and Palatin amend January 2007 collaboration agreement in obesity

July 4, 2008

VG-101 gel, safe and effective in mouse model of vaginal atrophy

July 4, 2008

CHMP adopts negative opinion for Howmedica's Opgenra

July 4, 2008

Snapshots of alogliptin studies

July 4, 2008

New antiobesity agents claimed in recent patents

July 3, 2008

Lev to submit Cinryze application to the EMEA for hereditary angioedema

July 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...